Mamdoh Eskandar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mamdoh Eskandar has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Ayman Hussien Shaamash
Department of Obstetrics and Gynecology, College of Medicine, King Khalid University, Abha, Saudi Arabia
3 shared publications - Mehad H. AlQasem
Department of Obstetrics and Gynecology, College of Medicine, King Khalid University, Abha, Saudi Arabia
2 shared publications Mohamed El-Amin
Saudi Center for Assisted Reproduction, Abha, Saudi Arabia
2 shared publicationsA. Abusham
Abha General Hospital, Abha, Saudi Arabia
1 shared publicationA. Bahar
College of Medicine, King Khalid University
1 shared publicationA. Sobande
1 shared publication
Latest Publications
- Open Access
- 10 November 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
The impact of previous caesarean delivery on IVF/ICSI outcomes: a large retrospective cohort study from Saudi Arabia
- 10 November 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
Open AccessThe impact of previous caesarean delivery on IVF/ICSI outcomes: a large retrospective cohort study from Saudi Arabia
- Open Access
- 10 September 2026
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 31 (1) , 72
Cabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
Background: Dopamine agonists are increasingly used to prevent ovarian hyperstimulation syndrome (OHSS), but the evidence remains fragmented. We synthesized comparative evidence on cabergoline for preventing moderate-to-severe OHSS in women undergoing IVF/ICSI, analysing randomized and non-randomized evidence as separate evidence streams. Methods: PubMed/MEDLINE, Embase, and the Cochrane Library were searched from inception to 1 May 2026. Randomized controlled trials (RCTs) and prospective non-randomized comparative studies comparing cabergoline with placebo or no treatment were eligible. Two reviewers independently performed selection, data extraction, and risk-of-bias assessment (RoB 2, ROBINS-I). In accordance with Cochrane guidance, randomized and non-randomized studies were not combined: the pooled estimate from the RCTs constituted the primary analysis, and the non-randomized studies were pooled separately as supportive evidence. Moderate-to-severe OHSS was expressed as an odds ratio (OR) using a random-effects model; certainty was rated with GRADE for each evidence stream. Results: Eight studies (969 women) were included: six RCTs (748 women) and two prospective non-randomized comparative studies (221 women). In the primary analysis restricted to the six RCTs, cabergoline was associated with a lower incidence of moderate-to-severe OHSS (OR 0.41, 95% CI 0.26–0.64; I² = 18%; 138 events). The two non-randomized studies, analysed separately, gave a consistent estimate (OR 0.21, 95% CI 0.07–0.66; I² = 0%). Assuming a baseline risk of 100 per 1,000 women, this corresponds to 57 fewer cases of moderate-to-severe OHSS per 1,000 women (95% CI 34 to 72 fewer). The estimate was robust in leave-one-out analysis (range OR 0.33–0.47) and after excluding the trial subject to an Expression of Concern (OR 0.42, 95% CI 0.25–0.73). No funnel-plot asymmetry was detected (Egger’s P = 0.90), but with six trials publication bias could not be reliably excluded. Clinical pregnancy, live birth, and adverse events were inconsistently reported and were not pooled. Certainty of evidence was Low for the randomized stream and Very low for the non-randomized stream. Conclusions: Low-certainty evidence indicates that cabergoline may reduce the incidence of moderate-to-severe OHSS in women undergoing IVF/ICSI. The available data did not identify a clear adverse signal for clinical pregnancy, live birth, or maternal adverse events, but were insufficient to determine these effects reliably. Cabergoline should be positioned as an adjunctive measure alongside, not instead of, contemporary primary prevention strategies.
- 10 September 2026
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 31 (1) , 72
Open AccessCabergoline for reducing the incidence of Ovarian Hyperstimulation Syndrome (OHSS) in women undergoing IVF/ICSI: a systematic review and meta-analysis of randomized controlled trials
Background: Dopamine agonists are increasingly used to prevent ovarian hyperstimulation syndrome (OHSS), but the evidence remains fragmented. We synthesized comparative evidence on cabergoline for preventing moderate-to-severe OHSS in women undergoing IVF/ICSI, analysing randomized and non-randomized evidence as separate evidence streams. Methods: PubMed/MEDLINE, Embase, and the Cochrane Library were searched from inception to 1 May 2026. Randomized controlled trials (RCTs) and prospective non-randomized comparative studies comparing cabergoline with placebo or no treatment were eligible. Two reviewers independently performed selection, data extraction, and risk-of-bias assessment (RoB 2, ROBINS-I). In accordance with Cochrane guidance, randomized and non-randomized studies were not combined: the pooled estimate from the RCTs constituted the primary analysis, and the non-randomized studies were pooled separately as supportive evidence. Moderate-to-severe OHSS was expressed as an odds ratio (OR) using a random-effects model; certainty was rated with GRADE for each evidence stream. Results: Eight studies (969 women) were included: six RCTs (748 women) and two prospective non-randomized comparative studies (221 women). In the primary analysis restricted to the six RCTs, cabergoline was associated with a lower incidence of moderate-to-severe OHSS (OR 0.41, 95% CI 0.26–0.64; I² = 18%; 138 events). The two non-randomized studies, analysed separately, gave a consistent estimate (OR 0.21, 95% CI 0.07–0.66; I² = 0%). Assuming a baseline risk of 100 per 1,000 women, this corresponds to 57 fewer cases of moderate-to-severe OHSS per 1,000 women (95% CI 34 to 72 fewer). The estimate was robust in leave-one-out analysis (range OR 0.33–0.47) and after excluding the trial subject to an Expression of Concern (OR 0.42, 95% CI 0.25–0.73). No funnel-plot asymmetry was detected (Egger’s P = 0.90), but with six trials publication bias could not be reliably excluded. Clinical pregnancy, live birth, and adverse events were inconsistently reported and were not pooled. Certainty of evidence was Low for the randomized stream and Very low for the non-randomized stream. Conclusions: Low-certainty evidence indicates that cabergoline may reduce the incidence of moderate-to-severe OHSS in women undergoing IVF/ICSI. The available data did not identify a clear adverse signal for clinical pregnancy, live birth, or maternal adverse events, but were insufficient to determine these effects reliably. Cabergoline should be positioned as an adjunctive measure alongside, not instead of, contemporary primary prevention strategies.
- Open Access
- 21 February 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (8) , e41656
Coronavirus disease 2019 vaccination and menstrual cycle changes: A cross-sectional study on females of reproductive age in Saudi Arabia
Data supporting the evidence of changes in the menstrual cycle and premenstrual symptoms associated with coronavirus disease (COVID-19) is quite scarce. To determine the association between COVID-19 vaccination and menstrual cycle changes and its relationship with different types of vaccines among women of reproductive age in Abha City, Saudi Arabia. A cross-sectional study was conducted from January 2022 to June 2022, among participants from Asser region of Saudi Arabia by using a self-administered questionnaire through an electronic survey. Data analysis was performed using SPSS version 16.0. Among 1208 study subjects, majority (66.9%) of females had menarche at the age of <13 years, 17.2% had irregular periods, and 24.8% reported an average regularity of periods (23–35 days). A statistically significant association was found among females who experienced a change in their menstrual cycle after receiving COVID-19 vaccine. Mood swings and lower back pain were common symptoms of premenstrual syndrome symptoms. Only 15% females reported a delay in conception. Out of 176 females, 40% showed 6 month delay in conception after receiving vaccine. Multivariate logistic regression analysis showed that age, regularity of periods, and usual volume of bleeding were significantly associated with changes in the menstrual cycle after vaccination. The relationship between COVID-19 vaccine and associated changes on the menstrual cycle and premenstrual syndrome was established in our study. Further research is needed to produce concrete evidence regarding its relationship to eliminate vaccine hesitancy among women.
- 21 February 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (8) , e41656
Open AccessCoronavirus disease 2019 vaccination and menstrual cycle changes: A cross-sectional study on females of reproductive age in Saudi Arabia
Data supporting the evidence of changes in the menstrual cycle and premenstrual symptoms associated with coronavirus disease (COVID-19) is quite scarce. To determine the association between COVID-19 vaccination and menstrual cycle changes and its relationship with different types of vaccines among women of reproductive age in Abha City, Saudi Arabia. A cross-sectional study was conducted from January 2022 to June 2022, among participants from Asser region of Saudi Arabia by using a self-administered questionnaire through an electronic survey. Data analysis was performed using SPSS version 16.0. Among 1208 study subjects, majority (66.9%) of females had menarche at the age of <13 years, 17.2% had irregular periods, and 24.8% reported an average regularity of periods (23–35 days). A statistically significant association was found among females who experienced a change in their menstrual cycle after receiving COVID-19 vaccine. Mood swings and lower back pain were common symptoms of premenstrual syndrome symptoms. Only 15% females reported a delay in conception. Out of 176 females, 40% showed 6 month delay in conception after receiving vaccine. Multivariate logistic regression analysis showed that age, regularity of periods, and usual volume of bleeding were significantly associated with changes in the menstrual cycle after vaccination. The relationship between COVID-19 vaccine and associated changes on the menstrual cycle and premenstrual syndrome was established in our study. Further research is needed to produce concrete evidence regarding its relationship to eliminate vaccine hesitancy among women.
- Open Access
Assessment of Women’s Awareness of the Possible Risk of Stroke Associated with the Use of Oral Contraceptives Pills in Saudi Arabia: A Cross-Sectional Study
Background and Objectives: One of the most widely used reversible contraceptive techniques among women of reproductive age worldwide is oral contraceptives (OCPs). Despite their widespread use, OCPs are associated with increased risks of stroke, yet the extent of awareness of these risks among women remains insufficiently explored. This study aims to evaluate the level of awareness among women resident in Saudi Arabia regarding the potential risk of stroke linked to the use of OCPs. Materials and Methods: A cross-sectional descriptive study was conducted targeting women of reproductive age (18–49 years). Data was collected through an online self-administrated questionnaire distributed via social media platforms, encompassing sociodemographic characteristics, OCP usage patterns, and awareness of stroke risks, perceived side effects of OCPs, symptoms of stroke, and methods to reduce stroke incidence. Statistical analysis was performed using SPSS version 23, with descriptive statistics for categorical data and chi-square tests to assess associations. Results: A total of 516 women participated in the study. Of these, 148, or over a quarter (28.7%), of the participants reported using oral contraceptive pills; 86, or more than half (58%), who use OCPs are not sure what type of OCPs they use; 60, or over half of the participants (40.5%), have been using for less than a year. Over two thirds of the participants (350, 67.8%) are not aware that using OCP increases the risk of stroke. The most recognized side effect of OCPs use was weight gain (38.2%), while awareness of stroke as a side effect was significantly lower (24.6%). Additionally, 62.8% of respondents identified selecting the appropriate type of contraceptive as the best way to prevent stroke while taking OCPs. Conclusions: this study highlights the need for increased awareness and education about the potential risk of cerebral thrombosis associated with OCP use among Saudi women. Addressing this knowledge gap through targeted educational initiatives could help mitigate the risks and improve overall public health outcomes.
Open AccessAssessment of Women’s Awareness of the Possible Risk of Stroke Associated with the Use of Oral Contraceptives Pills in Saudi Arabia: A Cross-Sectional Study
Background and Objectives: One of the most widely used reversible contraceptive techniques among women of reproductive age worldwide is oral contraceptives (OCPs). Despite their widespread use, OCPs are associated with increased risks of stroke, yet the extent of awareness of these risks among women remains insufficiently explored. This study aims to evaluate the level of awareness among women resident in Saudi Arabia regarding the potential risk of stroke linked to the use of OCPs. Materials and Methods: A cross-sectional descriptive study was conducted targeting women of reproductive age (18–49 years). Data was collected through an online self-administrated questionnaire distributed via social media platforms, encompassing sociodemographic characteristics, OCP usage patterns, and awareness of stroke risks, perceived side effects of OCPs, symptoms of stroke, and methods to reduce stroke incidence. Statistical analysis was performed using SPSS version 23, with descriptive statistics for categorical data and chi-square tests to assess associations. Results: A total of 516 women participated in the study. Of these, 148, or over a quarter (28.7%), of the participants reported using oral contraceptive pills; 86, or more than half (58%), who use OCPs are not sure what type of OCPs they use; 60, or over half of the participants (40.5%), have been using for less than a year. Over two thirds of the participants (350, 67.8%) are not aware that using OCP increases the risk of stroke. The most recognized side effect of OCPs use was weight gain (38.2%), while awareness of stroke as a side effect was significantly lower (24.6%). Additionally, 62.8% of respondents identified selecting the appropriate type of contraceptive as the best way to prevent stroke while taking OCPs. Conclusions: this study highlights the need for increased awareness and education about the potential risk of cerebral thrombosis associated with OCP use among Saudi women. Addressing this knowledge gap through targeted educational initiatives could help mitigate the risks and improve overall public health outcomes.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 126 (C) , 110752
A narrative review on the practice of genital mutilation among Arab adolescent females and a case report on a large clitoral epidermal inclusion cyst
Introduction and importance: Female circumcision, also known as female genital mutilation/cutting (FGM/C), is a common practice in many Arab countries, including Egypt. One potential complication of FGM/C is the development of a clitoral epidermal inclusion cyst, which occurs when keratinized epithelial cells and sebaceous glands become incorporated into the circumcision scar line in the clitoral or labial area. The objective of this study is to present a rare case of a large clitoral epidermal inclusion cyst following FGM/C and to review the current practice of FGM/C in the Arab world, including Egypt, Sudan, and Saudi Arabia. A retrospective review of medical records for a single rare case and a literature search on PubMed were conducted to gather information on FGM/C in Egypt and the Arab region. Case presentation: A newly married 19-year-old Egyptian adolescent female presented with a large (~5 × 5 cm) painless clitoral swelling, 11 years after undergoing FGM/C. A complete history, perineal examination, and ultrasonography suggested a clitoral swelling, with the top differential diagnosis being an “epidermal inclusion cyst”. During surgery, a cystic swelling was dissected and enucleated with the capsule intact. Clinical discussion: Histopathology of the specimen confirmed the presence of an epidermal inclusion cyst, most likely related to the previous FGM/C during her childhood. Clitoral epidermal inclusion cysts can arise many years after FGM/C. Conclusion: Surgical intervention is successful in treating this rare and longterm post-circumcision complication. The practice of FGM/C remains prevalent among adolescent females in Egypt and many other Arab countries. Highlights:
- 1 January 2025
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 126 (C) , 110752
Open AccessA narrative review on the practice of genital mutilation among Arab adolescent females and a case report on a large clitoral epidermal inclusion cyst
Introduction and importance: Female circumcision, also known as female genital mutilation/cutting (FGM/C), is a common practice in many Arab countries, including Egypt. One potential complication of FGM/C is the development of a clitoral epidermal inclusion cyst, which occurs when keratinized epithelial cells and sebaceous glands become incorporated into the circumcision scar line in the clitoral or labial area. The objective of this study is to present a rare case of a large clitoral epidermal inclusion cyst following FGM/C and to review the current practice of FGM/C in the Arab world, including Egypt, Sudan, and Saudi Arabia. A retrospective review of medical records for a single rare case and a literature search on PubMed were conducted to gather information on FGM/C in Egypt and the Arab region. Case presentation: A newly married 19-year-old Egyptian adolescent female presented with a large (~5 × 5 cm) painless clitoral swelling, 11 years after undergoing FGM/C. A complete history, perineal examination, and ultrasonography suggested a clitoral swelling, with the top differential diagnosis being an “epidermal inclusion cyst”. During surgery, a cystic swelling was dissected and enucleated with the capsule intact. Clinical discussion: Histopathology of the specimen confirmed the presence of an epidermal inclusion cyst, most likely related to the previous FGM/C during her childhood. Clitoral epidermal inclusion cysts can arise many years after FGM/C. Conclusion: Surgical intervention is successful in treating this rare and longterm post-circumcision complication. The practice of FGM/C remains prevalent among adolescent females in Egypt and many other Arab countries. Highlights:
- Open Access
- 1 January 2011
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 3 (1) , 30-5
Early Maternal Serum β-human Chorionic Gonadotropin Measurements After ICSI in the Prediction of Long-term Pregnancy Outcomes: A Retrospective Cohort Analysis
Initial low maternal serum β-human chorionic gonadotropin (β-hCG) is a good predictor of early pregnancy demise. Our objective was to determine its predictive value in determining the long-term outcome in ICSI pregnancies. A retrospective cohort study was designed at the Saudi Center for Assisted Reproduction. Two hundred and sixty-one women with ICSI pregnancies were followed up from initial β-hCG level determination till the end of pregnancy. Accuracy of early β-hCG in predicting the occurrence of a live-birth, ongoing pregnancy, late miscarriage, ectopic pregnancy and early miscarriage following ICSI was measured. β-hCG levels were significantly different in pregnancies that reached the stage of an ongoing pregnancy and live-birth as compared to early pregnancy loss. The ROC curves demonstrated a high sensitivity for identifying patients with ectopic pregnancies and early miscarriage (100% and 93.33% respectively). The remaining results ranged from a sensitivity of 69% to 79% and specificity of 62% to 75%. In ICSI pregnancies, a single early β-hCG may help to identify pregnancies that will reach full-term and delivery. ICSI; Human chorionic gonadotropin; Outcome; Pregnancy.
- 1 January 2011
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 3 (1) , 30-5
Open AccessEarly Maternal Serum β-human Chorionic Gonadotropin Measurements After ICSI in the Prediction of Long-term Pregnancy Outcomes: A Retrospective Cohort Analysis
Initial low maternal serum β-human chorionic gonadotropin (β-hCG) is a good predictor of early pregnancy demise. Our objective was to determine its predictive value in determining the long-term outcome in ICSI pregnancies. A retrospective cohort study was designed at the Saudi Center for Assisted Reproduction. Two hundred and sixty-one women with ICSI pregnancies were followed up from initial β-hCG level determination till the end of pregnancy. Accuracy of early β-hCG in predicting the occurrence of a live-birth, ongoing pregnancy, late miscarriage, ectopic pregnancy and early miscarriage following ICSI was measured. β-hCG levels were significantly different in pregnancies that reached the stage of an ongoing pregnancy and live-birth as compared to early pregnancy loss. The ROC curves demonstrated a high sensitivity for identifying patients with ectopic pregnancies and early miscarriage (100% and 93.33% respectively). The remaining results ranged from a sensitivity of 69% to 79% and specificity of 62% to 75%. In ICSI pregnancies, a single early β-hCG may help to identify pregnancies that will reach full-term and delivery. ICSI; Human chorionic gonadotropin; Outcome; Pregnancy.
- Open Access
- 1 July 2009
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 26 (7) , 377-381
Congenital anomalies and other perinatal outcomes in ICSI vs. naturally conceived pregnancies: a comparative study
Intracytoplasmic sperm injection (ICSI) procedures have become accepted worldwide and their effect on society is well-known. However, the full extent of the possible complications of these procedures on maternal and neonatal outcome is still unclear. This is a retrospective case controlled study from January 2003 to December 2007 which compared 253 women that had conceived using assisted reproduction (ICSI) and delivered 327 children at our center (study group) with a matched group of 349 women who naturally conceived and delivered 354 children at Abha General Hospital (control group) during the same period. The obstetrical and neonatal characteristics of the women and their children were assessed to determine any significant differences between the groups. The number of gestations per pregnancy (1.34 ± 0.57 vs. 1.01 ± 0.12) and number of children born per woman (1.28 ± 0.49 vs. 1.01 ± 0.12) was significantly higher in the ICSI group (p < 0.001). In addition, the gestational age at delivery (37.23 ± 2.68 vs. 38.56 ± 1.89) was significantly shorter in the ICSI group (p < 0.001) and this led to an increased number of obstetrical interventions, as well as the incidence of cesarean deliveries. Examination of the new-born children revealed similar incidence of congenital anomalies in both groups. ICSI conceived pregnancies were characterized by an increased number of gestations and live-born, and there was no increase in congenital malformations compared to naturally conceived pregnancies.
- 1 July 2009
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 26 (7) , 377-381
Open AccessCongenital anomalies and other perinatal outcomes in ICSI vs. naturally conceived pregnancies: a comparative study
Intracytoplasmic sperm injection (ICSI) procedures have become accepted worldwide and their effect on society is well-known. However, the full extent of the possible complications of these procedures on maternal and neonatal outcome is still unclear. This is a retrospective case controlled study from January 2003 to December 2007 which compared 253 women that had conceived using assisted reproduction (ICSI) and delivered 327 children at our center (study group) with a matched group of 349 women who naturally conceived and delivered 354 children at Abha General Hospital (control group) during the same period. The obstetrical and neonatal characteristics of the women and their children were assessed to determine any significant differences between the groups. The number of gestations per pregnancy (1.34 ± 0.57 vs. 1.01 ± 0.12) and number of children born per woman (1.28 ± 0.49 vs. 1.01 ± 0.12) was significantly higher in the ICSI group (p < 0.001). In addition, the gestational age at delivery (37.23 ± 2.68 vs. 38.56 ± 1.89) was significantly shorter in the ICSI group (p < 0.001) and this led to an increased number of obstetrical interventions, as well as the incidence of cesarean deliveries. Examination of the new-born children revealed similar incidence of congenital anomalies in both groups. ICSI conceived pregnancies were characterized by an increased number of gestations and live-born, and there was no increase in congenital malformations compared to naturally conceived pregnancies.
- 1 October 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 90 (4) , 1187-1190
Ultrasound guidance during embryo transfer: a prospective, single-operator, randomized, controlled trial
- 1 October 2008
- Published by Elsevier in Fertility and Sterility
- Vol. 90 (4) , 1187-1190
Ultrasound guidance during embryo transfer: a prospective, single-operator, randomized, controlled trial
- Open Access
- 28 August 2007
- Published by Springer Nature in Journal of Experimental & Clinical Assisted Reproduction
- Vol. 4 (1) , 3
Regional clinical practice patterns in reproductive endocrinology: A collaborative transnational pilot survey of in vitro fertilization programs in the Middle East
- 28 August 2007
- Published by Springer Nature in Journal of Experimental & Clinical Assisted Reproduction
- Vol. 4 (1) , 3
Open AccessRegional clinical practice patterns in reproductive endocrinology: A collaborative transnational pilot survey of in vitro fertilization programs in the Middle East